Slottsviken Fastighetsaktiebolag (publ)

Research Slottsviken Fastighetsaktiebolag (publ) (SLOTT-B.ST) on Bullrun: market cap SEK 49.20M, P/E 19.7, dividend yield 0.5%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is SEK 49.20M; P/E is 19.7; dividend yield is 0.5%.

Peer valuation comparison

Latest P/E is 19.69x versus a Real Estate sector median of 13.11x (50.2% above).

Latest dividend yield is 0.49% versus a Real Estate sector median of 4.63% (89.4% below).

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-18SEK 49.20M19.70.5%0.12

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0.12 SEK, yield 0.5%.

About Slottsviken Fastighetsaktiebolag (publ)

Slottsviken Fastighetsaktiebolag (publ), a real estate company, acquires, develops, and manages properties in Sweden and internationally. The company property portfolio includes residential properties; and commercial premises for production, retail/trade, restaurants, industry, workshops, logistics, and offices. It also invests in securities; and owns and manages intellectual property rights relating to Reumacon and Wartec life science activities.

Related stock research

Other Real Estate stocks

Frequently asked questions

What is Slottsviken Fastighetsaktiebolag (publ)'s market cap?

Slottsviken Fastighetsaktiebolag (publ)'s market capitalization is SEK 49.20M.

What is Slottsviken Fastighetsaktiebolag (publ)'s P/E ratio?

Slottsviken Fastighetsaktiebolag (publ)'s price-to-earnings (P/E) ratio is 19.7.

Does Slottsviken Fastighetsaktiebolag (publ) pay a dividend?

Slottsviken Fastighetsaktiebolag (publ) has a dividend yield of 0.5%.

What does Slottsviken Fastighetsaktiebolag (publ) do?

Slottsviken Fastighetsaktiebolag (publ), a real estate company, acquires, develops, and manages properties in Sweden and internationally. The company property portfolio includes residential properties; and commercial premises for production, retail/trade, restaurants, industry, workshops, logistics, and offices. It also invests in securities; and owns and manages intellectual property rights relating to Reumacon and Wartec life science activities. The company was formerly known as Conpharm AB (publ) and changed its name to Slottsviken Fastighetsaktiebolag (publ) in July 2015.